Just to add to all this about this trial.
go and look at presentations on website
they have been using BTM off label in flinders hospital for a few years now in management of complex diabetic foot ulcers.
I presented their findings to a group of podiatrists a few months ago.
this trial is basically a rework of BTM with a few simple changes to have an on label product for something they have already been using BTM off label for.
I said to this forum about 18 months ago that people are sleeping on how DFU is probably a much larger market here than Burns.
do your own research, but for those interested highly recommend watching the presentation on it but hat is available on PNV website
Ann: First Patient enrolled - SynPath Diabetic Foot Ulcer Trial, page-30
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.35 |
Change
-0.040(1.67%) |
Mkt cap ! $1.623B | |||
| Open | High | Low | Value | Volume |
| $2.41 | $2.41 | $2.34 | $1.491M | 631.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3816 | $2.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.36 | 8900 | 2 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |